In the world there are increasingly more people with excess weight. The World Health Organization (who) does not hesitate to speak of an epidemic of obesity, which exposes millions of people to medical complications and constitutes one of the major public health problems. At the same time habits like smoking decrease the strength of our lungs and create problems in our respiratory system. Both these if they are coupled together can be real challenge for your healthy life. Understand the profound impact of the French company Sanofi-Synthelabo of these two passive diseases has risen with a two-in-one medication for the two known as Acomplia. Mainly known as Rimonabant Acomplia acts as an appetite suppressant for weight reduction. Clinical studies have shown that 1 in 3 people who have followed a treatment with Acomplia has been able to lose 10% of their body weight without having a single pound for the next 2 years. Most of the patients that have been used Acomplia lost around 20 pounds.
Acomplia the safe and effective pill for Acomplia (Rimonabant) weight loss also reduces the resumption of the cocaina-adictos responses, as well as reduce ethanol and opiate search behavior. Studies have shown that Acomplia (Rimonabant) blocks the psychoactive and some of the cardiovascular effects of cannabis also. Judging by early results, this medication will become very popular in recent years. It turns out that Rimonabant Acomplia cure obesity with much success and helps to get rid of the bad habit of smoking. Active components block brain receptors, which are linked to the Anadamida biological substance that increases appetite and maintains the inclination to smoke. The results in the first 6 000 patients give much hope. The drug proved to be very effective and do not have serious side effects. About 90% of patients taking the medicine they managed to lose weight significantly. This drug was able to normalize the indices of blood lipids of many patients and improve control diabetic people who suffered from this disease.
